You can now read 10 articles in a month for free on Read as much as you want anywhere and anytime for just 99¢.

The Boston Globe


Mersana, Merck Serono announce new oncology partnership

Mersana Therapeutics Inc. and Merck Serono said Tuesday that they will collaborate on antibody-drug conjugates that can be used to develop potential cancer treatments.

Headquartered in Cambridge, Mersana is working on an antibody-drug conjugate platform that is designed for the delivery of drugs; these conjugates can be loaded with a drug payload that is released once inside a targeted cancer cell.

Loading comments...

You have reached the limit of 10 free articles in a month

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week